atRA also augmented LSC abundance, quiescence, and activity in an MLL-AF9 driven murine AML model in a manner dependent on transformed cell type (LSK cells vs. CMPs) and Evi1 expression [17]. This evidence concerns the gene MECOM and acute myeloid leukemia.